Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable patch could help detect seizures in real time

NCT ID NCT05637762

Knowledge-focused Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to create a database of heart rate and movement data from 13 adults with drug-resistant epilepsy. Participants wore a connected patch that recorded heart rate and motion, while also undergoing video-EEG monitoring to confirm when seizures occurred. The goal was to use this information to develop an algorithm that can automatically detect seizures, which could help reduce stress from unpredictable seizures and guide treatment adjustments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

13 people

The number who actually took part.

Started

Jun 2023

Finished

Apr 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The people with epilepsy will be recruited from among the patients/residents being followed for their epilepsy at the Institut La Teppe. Institut La Teppe is a medical and social institution that welcomes people suffering from epilepsy with cognitive deficiencies that can be severe.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Person over 18 years of age - With drug-resistant epilepsy as defined by the International League Against Epilepsy * Who has at least one recorded seizure with heart rate variation (i.e. tachycardia defined as an increase of 30 bpm or more than 50% over the interictal heart rate and/or bradycardia defined as a heart rate \< 40 bpm or ictal asystole defined as an R-R interval greater than 3 seconds and usually lasting less than 60 seconds) * Informed about the study and signed a consent to participate in the study (and their legal representative for patients under guardianship) * Affiliated or beneficiary of a social insurance plan Exclusion Criteria: * Pregnant or breastfeeding woman * Persons with psychogenic non-epileptic seizures (PNES) * Person with a history of severe heart disease (myocardial infarction, heart failure, rhythm disorder, severe hypertension) * Persons with an implantable cardiac device (pacemaker, implantable defibrillator) * Documented allergy to hydrogel and/or acrylate * Person benefiting from a legal protection measure other than guardianship or curatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy

Contacts and locations

Locations

  • Institut La Teppe

    Tain-l'Hermitage, 26600, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.